▶ 調査レポート

世界のフィナステリド経口錠剤市場 2028年:1mg錠、5mg錠

• 英文タイトル:Global Finasteride Oral Tablet Market Insights, Forecast to 2028

Global Finasteride Oral Tablet Market Insights, Forecast to 2028「世界のフィナステリド経口錠剤市場 2028年:1mg錠、5mg錠」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C3833
• 出版社/出版日:QYResearch / 2022年7月11日
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のフィナステリド経口錠剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフィナステリド経口錠剤の世界市場のxxx%を占める「1mg錠」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「良性前立腺肥大症」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のフィナステリド経口錠剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフィナステリド経口錠剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのフィナステリド経口錠剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

フィナステリド経口錠剤のグローバル主要メーカーには、Merck、Accord Healthcare UK、Relonchem、Sandoz、Teva Generics、Cipla、Dr. Reddy、Aurobindo Pharma、Henan Topfond、Zhejiang CONBA Pharmaceutical、Shandong Renhetang Pharmaceutical、Guangdong Eashu Pharmacetical、Shanghai Shyndec Pharmaceutical Co.,Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

フィナステリド経口錠剤市場は、種類と用途によって区分されます。世界のフィナステリド経口錠剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
1mg錠、5mg錠

【用途別セグメント】
良性前立腺肥大症、男性型脱毛症、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- フィナステリド経口錠剤製品概要
- 種類別市場(1mg錠、5mg錠)
- 用途別市場(良性前立腺肥大症、男性型脱毛症、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のフィナステリド経口錠剤販売量予測2017-2028
- 世界のフィナステリド経口錠剤売上予測2017-2028
- フィナステリド経口錠剤の地域別販売量
- フィナステリド経口錠剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別フィナステリド経口錠剤販売量
- 主要メーカー別フィナステリド経口錠剤売上
- 主要メーカー別フィナステリド経口錠剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(1mg錠、5mg錠)
- フィナステリド経口錠剤の種類別販売量
- フィナステリド経口錠剤の種類別売上
- フィナステリド経口錠剤の種類別価格
・用途別市場規模(良性前立腺肥大症、男性型脱毛症、その他)
- フィナステリド経口錠剤の用途別販売量
- フィナステリド経口錠剤の用途別売上
- フィナステリド経口錠剤の用途別価格
・北米市場
- 北米のフィナステリド経口錠剤市場規模(種類別、用途別)
- 主要国別のフィナステリド経口錠剤市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのフィナステリド経口錠剤市場規模(種類別、用途別)
- 主要国別のフィナステリド経口錠剤市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のフィナステリド経口錠剤市場規模(種類別、用途別)
- 主要国別のフィナステリド経口錠剤市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のフィナステリド経口錠剤市場規模(種類別、用途別)
- 主要国別のフィナステリド経口錠剤市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのフィナステリド経口錠剤市場規模(種類別、用途別)
- 主要国別のフィナステリド経口錠剤市場規模(トルコ、サウジアラビア)
・企業情報
Merck、Accord Healthcare UK、Relonchem、Sandoz、Teva Generics、Cipla、Dr. Reddy、Aurobindo Pharma、Henan Topfond、Zhejiang CONBA Pharmaceutical、Shandong Renhetang Pharmaceutical、Guangdong Eashu Pharmacetical、Shanghai Shyndec Pharmaceutical Co.,Ltd.
・産業チェーン及び販売チャネル分析
- フィナステリド経口錠剤の産業チェーン分析
- フィナステリド経口錠剤の原材料
- フィナステリド経口錠剤の生産プロセス
- フィナステリド経口錠剤の販売及びマーケティング
- フィナステリド経口錠剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- フィナステリド経口錠剤の産業動向
- フィナステリド経口錠剤のマーケットドライバー
- フィナステリド経口錠剤の課題
- フィナステリド経口錠剤の阻害要因
・主な調査結果

Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).
Market Analysis and Insights: Global Finasteride Oral Tablet Market
Due to the COVID-19 pandemic, the global Finasteride Oral Tablet market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 1mg Tablet accounting for % of the Finasteride Oral Tablet global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Benign Prostatic Hyperplasia segment is altered to an % CAGR throughout this forecast period.
China Finasteride Oral Tablet market size is valued at US$ million in 2021, while the US and Europe Finasteride Oral Tablet are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Finasteride Oral Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Finasteride Oral Tablet include Merck, Accord Healthcare UK, Relonchem, Sandoz, Teva Generics, Cipla, Dr. Reddy, Aurobindo Pharma and Henan Topfond, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Finasteride Oral Tablet Scope and Segment
Finasteride Oral Tablet market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Finasteride Oral Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
1mg Tablet
5mg Tablet
Segment by Application
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
By Company
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Finasteride Oral Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Finasteride Oral Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Market by Application
1.3.1 Global Finasteride Oral Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Finasteride Oral Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Finasteride Oral Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Finasteride Oral Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Finasteride Oral Tablet Sales by Region
2.4.1 Global Finasteride Oral Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Finasteride Oral Tablet by Region (2023-2028)
2.5 Global Finasteride Oral Tablet Revenue by Region
2.5.1 Global Finasteride Oral Tablet Revenue by Region (2017-2022)
2.5.2 Global Finasteride Oral Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Finasteride Oral Tablet Sales by Manufacturers
3.1.1 Global Top Finasteride Oral Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Finasteride Oral Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Finasteride Oral Tablet in 2021
3.2 Global Finasteride Oral Tablet Revenue by Manufacturers
3.2.1 Global Finasteride Oral Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Finasteride Oral Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Finasteride Oral Tablet Revenue in 2021
3.3 Global Finasteride Oral Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Finasteride Oral Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Finasteride Oral Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Finasteride Oral Tablet Sales by Type
4.1.1 Global Finasteride Oral Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Finasteride Oral Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Finasteride Oral Tablet Sales Market Share by Type (2017-2028)
4.2 Global Finasteride Oral Tablet Revenue by Type
4.2.1 Global Finasteride Oral Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Finasteride Oral Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Finasteride Oral Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Finasteride Oral Tablet Price by Type
4.3.1 Global Finasteride Oral Tablet Price by Type (2017-2022)
4.3.2 Global Finasteride Oral Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Finasteride Oral Tablet Sales by Application
5.1.1 Global Finasteride Oral Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Finasteride Oral Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Finasteride Oral Tablet Sales Market Share by Application (2017-2028)
5.2 Global Finasteride Oral Tablet Revenue by Application
5.2.1 Global Finasteride Oral Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Finasteride Oral Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Finasteride Oral Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Finasteride Oral Tablet Price by Application
5.3.1 Global Finasteride Oral Tablet Price by Application (2017-2022)
5.3.2 Global Finasteride Oral Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Finasteride Oral Tablet Market Size by Type
6.1.1 North America Finasteride Oral Tablet Sales by Type (2017-2028)
6.1.2 North America Finasteride Oral Tablet Revenue by Type (2017-2028)
6.2 North America Finasteride Oral Tablet Market Size by Application
6.2.1 North America Finasteride Oral Tablet Sales by Application (2017-2028)
6.2.2 North America Finasteride Oral Tablet Revenue by Application (2017-2028)
6.3 North America Finasteride Oral Tablet Market Size by Country
6.3.1 North America Finasteride Oral Tablet Sales by Country (2017-2028)
6.3.2 North America Finasteride Oral Tablet Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Finasteride Oral Tablet Market Size by Type
7.1.1 Europe Finasteride Oral Tablet Sales by Type (2017-2028)
7.1.2 Europe Finasteride Oral Tablet Revenue by Type (2017-2028)
7.2 Europe Finasteride Oral Tablet Market Size by Application
7.2.1 Europe Finasteride Oral Tablet Sales by Application (2017-2028)
7.2.2 Europe Finasteride Oral Tablet Revenue by Application (2017-2028)
7.3 Europe Finasteride Oral Tablet Market Size by Country
7.3.1 Europe Finasteride Oral Tablet Sales by Country (2017-2028)
7.3.2 Europe Finasteride Oral Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Finasteride Oral Tablet Market Size by Type
8.1.1 Asia Pacific Finasteride Oral Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Finasteride Oral Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Finasteride Oral Tablet Market Size by Application
8.2.1 Asia Pacific Finasteride Oral Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Finasteride Oral Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Finasteride Oral Tablet Market Size by Region
8.3.1 Asia Pacific Finasteride Oral Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Finasteride Oral Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Finasteride Oral Tablet Market Size by Type
9.1.1 Latin America Finasteride Oral Tablet Sales by Type (2017-2028)
9.1.2 Latin America Finasteride Oral Tablet Revenue by Type (2017-2028)
9.2 Latin America Finasteride Oral Tablet Market Size by Application
9.2.1 Latin America Finasteride Oral Tablet Sales by Application (2017-2028)
9.2.2 Latin America Finasteride Oral Tablet Revenue by Application (2017-2028)
9.3 Latin America Finasteride Oral Tablet Market Size by Country
9.3.1 Latin America Finasteride Oral Tablet Sales by Country (2017-2028)
9.3.2 Latin America Finasteride Oral Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Finasteride Oral Tablet Market Size by Type
10.1.1 Middle East and Africa Finasteride Oral Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Finasteride Oral Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Finasteride Oral Tablet Market Size by Application
10.2.1 Middle East and Africa Finasteride Oral Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Finasteride Oral Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Finasteride Oral Tablet Market Size by Country
10.3.1 Middle East and Africa Finasteride Oral Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Finasteride Oral Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Accord Healthcare UK
11.2.1 Accord Healthcare UK Corporation Information
11.2.2 Accord Healthcare UK Overview
11.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Accord Healthcare UK Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Accord Healthcare UK Recent Developments
11.3 Relonchem
11.3.1 Relonchem Corporation Information
11.3.2 Relonchem Overview
11.3.3 Relonchem Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Relonchem Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Relonchem Recent Developments
11.4 Sandoz
11.4.1 Sandoz Corporation Information
11.4.2 Sandoz Overview
11.4.3 Sandoz Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sandoz Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sandoz Recent Developments
11.5 Teva Generics
11.5.1 Teva Generics Corporation Information
11.5.2 Teva Generics Overview
11.5.3 Teva Generics Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Generics Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Generics Recent Developments
11.6 Cipla
11.6.1 Cipla Corporation Information
11.6.2 Cipla Overview
11.6.3 Cipla Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cipla Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Dr. Reddy
11.7.1 Dr. Reddy Corporation Information
11.7.2 Dr. Reddy Overview
11.7.3 Dr. Reddy Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dr. Reddy Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dr. Reddy Recent Developments
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Corporation Information
11.8.2 Aurobindo Pharma Overview
11.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aurobindo Pharma Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aurobindo Pharma Recent Developments
11.9 Henan Topfond
11.9.1 Henan Topfond Corporation Information
11.9.2 Henan Topfond Overview
11.9.3 Henan Topfond Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Henan Topfond Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Henan Topfond Recent Developments
11.10 Zhejiang CONBA Pharmaceutical
11.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
11.10.2 Zhejiang CONBA Pharmaceutical Overview
11.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zhejiang CONBA Pharmaceutical Recent Developments
11.11 Shandong Renhetang Pharmaceutical
11.11.1 Shandong Renhetang Pharmaceutical Corporation Information
11.11.2 Shandong Renhetang Pharmaceutical Overview
11.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shandong Renhetang Pharmaceutical Recent Developments
11.12 Guangdong Eashu Pharmacetical
11.12.1 Guangdong Eashu Pharmacetical Corporation Information
11.12.2 Guangdong Eashu Pharmacetical Overview
11.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Guangdong Eashu Pharmacetical Recent Developments
11.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
11.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Corporation Information
11.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Overview
11.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Finasteride Oral Tablet Industry Chain Analysis
12.2 Finasteride Oral Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Finasteride Oral Tablet Production Mode & Process
12.4 Finasteride Oral Tablet Sales and Marketing
12.4.1 Finasteride Oral Tablet Sales Channels
12.4.2 Finasteride Oral Tablet Distributors
12.5 Finasteride Oral Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Finasteride Oral Tablet Industry Trends
13.2 Finasteride Oral Tablet Market Drivers
13.3 Finasteride Oral Tablet Market Challenges
13.4 Finasteride Oral Tablet Market Restraints
14 Key Findings in The Global Finasteride Oral Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer